Fenofibrate, a PPARα agonist which drives transcriptional activity, has been shown to reduce cancer cell growth in U-87-MG glioma cells and in other cancers (Saidi et al., 2006; Panigrahy et al., 2008; Han D. F. et al., 2015). The gene discussed is PPARA; the disease is central nervous system cancer.